miRNA-646 suppresses osteosarcoma cell metastasis by downregulating fibroblast growth factor 2 (FGF2). (Q38939833)

7 September 2017

miRNA-646 suppresses osteosarcoma cell metastasis by downregulating fibroblast growth factor 2 (FGF2). (English)

1 reference

7 September 2017

Xiao-hui Sun

1

1 reference

7 September 2017

Xiao-lin Geng

series ordinal

2

1 reference

7 September 2017

Jun Zhang

series ordinal

3

1 reference

7 September 2017

Chao Zhang

series ordinal

4

1 reference

7 September 2017

18 November 2014

1 reference

7 September 2017

1 reference

7 September 2017

36

1 reference

7 September 2017

3

1 reference

7 September 2017

2127-2134

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-014-2822-z

7 September 2017

0 references

cites work

Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2822-Z

MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2822-Z

The long and short of microRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2822-Z

MicroRNAs in cancer: small molecules with a huge impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2822-Z

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2822-Z

The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2822-Z

MicroRNAs in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2822-Z

miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2822-Z

MicroRNA-100 inhibits osteosarcoma cell proliferation by targeting Cyr61.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2822-Z

MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2822-Z

The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2822-Z

Differentially expressed microRNAs in the serum of cervical squamous cell carcinoma patients before and after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2822-Z

Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2822-Z

TIP30 is associated with progression and metastasis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2822-Z

Down-regulation of the miRNA-200 family at the invasive front of colorectal cancers with degraded basement membrane indicates EMT is involved in cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2822-Z

Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2822-Z

Fibroblast growth factors and their receptors in urological cancers: basic research and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2822-Z

Fibroblast growth factor signalling: from development to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2822-Z

Influence of basic fibroblast growth factor on the proliferation of non-small cell lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2822-Z

A novel decoy receptor fusion protein for FGF-2 potently inhibits tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2822-Z

MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2822-Z

Apurinic/apyrimidinic endonuclease 1 induced upregulation of fibroblast growth factor 2 and its receptor 3 induces angiogenesis in human osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2822-Z

Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25403884

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25403884

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25403884

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-014-2822-Z

1 reference

Dimensions Publication ID

7 September 2017

0 references

1 reference